Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: Importance of gastric hypermotility

Digestive Diseases and Sciences

Volumn 49, Issue 2, 2004, Pages 180-187

  Takeuchi, Koji ^a   Tanaka, Akiko ^a   Hayashi, Yujiro ^a   Kubo, Yoshiaki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

COX 2 expression; Gastric hypermotility; Indomethacin; NSAID induced gastric damage; SC 560

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ATROPINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; MESSENGER RNA; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN E2; ROFECOXIB;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ACID SECRETION; STOMACH DISEASE; STOMACH MOTILITY; STOMACH ULCER;

ANIMALS; ATROPINE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENZYME INHIBITORS; GASTRIC ACID; GASTRIC MUCOSA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MOTILITY; INDOMETHACIN; ISOENZYMES; LACTONES; MALE; OMEPRAZOLE; PEROXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STOMACH; STOMACH ULCER; SULFONES;

EID: 1642304336     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000017436.05273.fd     Document Type: Article

References (25)

1. Lanza FL: Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal antiinflammatory agents. Am J Med 13:19-24, 1984
2. Whittle BJR: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80:94-98, 1981
3. Mersereau WA, Hinchey EJ: Prevention of phenylbutazone ulcer in the rat by glucose: role of a glycoprivic receptor system. Am J Physiol 242:G429-G432, 1982
4. Takuechi K, Ueki S, Okabe S: Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 31:1114-1121, 1986
5. Takeuchi K, Ueshima K, Hironaka Y, Fujioka Y, Matsumoto J, Okabe S: Oxygen free radicals and lipid peroxidation in the pathogenesis of gastric mucosal lesions induced by indomethacin in rats. Digestion 49:175-184, 1991
6. Asako H, Kubes P, Wallace JL, Granger DN: Indomethacin-induced leukocyte adhesion in mesenteric venules; role of lipoxygenase products. Am J Physiol 262:G903-G908, 1992
7. Wallace JL, Keeman CM, Granger DN: Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 259:G462-G467, 1995
8. Elliott SL, Ferris RJ, Giraud AS, Cook GA, Skeljo MV, Yeomans ND: Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH. Clin Exp Pharmacol Physiol 23:432-434, 1996
9. Santucci L, Fiorucci S, Di Matteo FM: Role of tumor necrosis factor α release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 108:393-401, 1995
10. Kargman S, Charlesion S, Cartwright M, Frank J, Riendeaw D, Mancini J, Evans J, O'Neil G: Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111:445-454, 1993
11. Wallace JL, McKnight W, Reuter BK, Vergnolle N: NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase 1 and 2. Gastroeneterology 119:706-714, 2000
12. Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K: Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris 95:21-27, 2001
13. Tanaka A, Hase S, Miyazawa T, Takeuchi K: Up-regulation of COX-2 by inhibition of COX-1: A key to NSAID-induced intestinal damage. J Pharmacol Exp Ther 300:754-761, 2002
14. Tanaka A, Araki H, Hase S, Takeuchi K: Roles of COX-1 and COX-2 inhibition in nonsteroidal antiinflammatory drug-induced gastric damage in rats: Relation to functional responses. Aliment Pharmacol Ther 16:90-101, 2002
15. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K, Isakson PC: Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95:13313-13318, 1998
16. Chan CC, Boyce S, Bridear C, Ford-Hutchinson AW, Gordon R, Guay D, Li CS, Mancini J, Panneton M, Prasit P, Rasori R, Riendeau D, Roy P, Tagari P, Vickers P, Wong E, Rodger IW: Pharmacology of a selective cyclooxygenase-2 inhibitor L-745,337: a novel non-steroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and non-human primate stomach. J Pharmacol Exp Ther 274:1531-1537, 1995
17. Yamamoto O, Okada Y, Okabe S: Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig Dis Sci 29:394-401, 1984
18. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S: NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59, 1994
19. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D: Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression. Arch Biochem Biophys 307:361-368, 1993
20. Iso JY, Sun X-H, Kao T-H, Reece KS, Wu R: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolutiojn of the gene. Nucleic Acids Res 13:2485-2502, 1995
21. Castro GA, Roy SA, Stockstill RD: Trichinella spioralis: Peroxidase activity in isolated cells from the rat intestine. Exp Parasiol 36:307-315, 1974
22. Okada M, Niida H, Takeuchi K, Okabe S: Role of prostaglandin deficiency in pathogenetic mechanism of gastric lesions induced by indomethacin in rats. Dig Dis Sci 34:694-702, 1989
23. Takeuchi K, Okada M, Osano H, Ebara S: Enhanced microvascular permeability and lesion formation during gastric hypermotility induced by indomethacin and 2-deoxy-D-glucose. J Clin Gastroenterol 12:S76-S84, 1990
24. Suzuki K, Araki H, Mizoguchi H, Takeuchi K: E type prostaglandin inhibits indomethacin-induced gastric lesions in rats through EP1 receptors: Importance of antigastric motility action. Digestion 63:92-101, 2001
25. Suzuki K, Araki H, Komoike Y, Takeuchi K: Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats. Med Sci Monitor 6:908-914, 2000